Open Access
How to translate text using browser tools
1 April 2022 Myopathy with oval inclusions in a domestic shorthair cat
Eliot Gougeon, Thibaut Larcher, Mireille Ledevin, Yvonne McGrotty, Pierre Méheust
Author Affiliations +
Abstract

Case summary An 18-month-old castrated male domestic shorthair cat was presented with a 2-month history of collapse and severe weakness, particularly affecting the pelvic limbs. A biceps femoris muscle biopsy revealed excessive variability in myofibre size, mild necrosis, minimal centronucleation and scattered 10 µm intracytoplasmic oval inclusions. The inclusions appeared amphophilic with haematoxylin and eosin, blue with Gomori trichrome and unstained with nicotinamide adenine dinucleotide dehydrogenase tetrazolium reductase staining. ATPase staining revealed a normal mosaic pattern and atrophy of both type 1 and 2 myofibres. The pathological diagnosis was a myopathy with inclusions. In contrast to previous feline myofibre inclusions previously reported in the literature, inclusions were not identified after immunohistochemistry using anti-desmin, tubulin, spectrin, laminin, LAMP and LC3 antibodies. After supportive care and corticosteroid treatment, clinical improvement was noted and the cat was discharged 10 days after initial presentation. Clinical and neurological re-examinations were performed at 1, 3, 6 and 9 months after discharge. Owner contact at both 10 and 30 months post-discharge confirmed that persistent muscular weakness was present.

Relevance and novel information This case report describes a novel and slowly progressive feline myopathy associated with oval amphophilic inclusions unreactive to immunostaining, which have not been previously reported in feline myopathies.

© The Author(s) 2022
Eliot Gougeon, Thibaut Larcher, Mireille Ledevin, Yvonne McGrotty, and Pierre Méheust "Myopathy with oval inclusions in a domestic shorthair cat," Journal of Feline Medicine and Surgery Open Reports 8(1), (1 April 2022). https://doi.org/10.1177/20551169221081418
Accepted: 2 February 2022; Published: 1 April 2022
KEYWORDS
Immunostaining
inclusion
muscle
myopathy
Back to Top